Scott Kathleen D.
Related Filers (4)
- Dermata Therapeutics, Inc. (7)
- ARS Pharmaceuticals, Inc. (5)
- Conatus Pharmaceuticals Inc. (2)
- NKGen Biotech, Inc. (2)
- Show More ...
Ownership (16)
4
Wednesday, 2/14/2024
NKGen Biotech, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/5/2024
Dermata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2024
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/10/2023
NKGen Biotech, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 1/5/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/1/2022
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 11/10/2022
ARS Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 11/10/2022
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/7/2022
Dermata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/8/2022
Dermata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/8/2022
Dermata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/5/2022
Dermata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/17/2021
Dermata Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/12/2021
Dermata Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 11/19/2019
Conatus Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/19/2019
Conatus Pharmaceuticals Inc.: Initial statement of beneficial ownership of securities